Skip to main content

Volume 19 - Issue 10 - October, 2007

Case Report
08/01/2008
Farrukh Hussain, MD, FRCPC
Cardiogenic shock complicating myocardial infarction carries a poor prognosis. Data regarding percutaneous intervention in the very elderly with cardiogenic shock is sparse.1 Age is an independent risk factor for worse outcome with...
Cardiogenic shock complicating myocardial infarction carries a poor prognosis. Data regarding percutaneous intervention in the very elderly with cardiogenic shock is sparse.1 Age is an independent risk factor for worse outcome with...
Cardiogenic shock complicating...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Hafeez Ahmed, MD, MBBS; Jawad Kiani, MD; Fahim H. Jafary, MD, FACC
Percutaneous coronary intervention (PCI) is an established therapy for patients with symptomatic coronary artery disease including acute coronary syndromes. In patients presenting with ST-elevation myocardial infarction (STEMI), a...
Percutaneous coronary intervention (PCI) is an established therapy for patients with symptomatic coronary artery disease including acute coronary syndromes. In patients presenting with ST-elevation myocardial infarction (STEMI), a...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Walter L. Sobczyk, MD; Michael R. Recto, MD; Henry Sadlo, MD
The performance of transesophageal echocardiography (TEE) has become common in the routine assessment of patients who have had transient ischemic attacks (TIAs) or stroke. As part of the TEE evaluation, agitated saline is usually injected...
The performance of transesophageal echocardiography (TEE) has become common in the routine assessment of patients who have had transient ischemic attacks (TIAs) or stroke. As part of the TEE evaluation, agitated saline is usually injected...
The performance of...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Carlo Trani, MD; Giuseppe Ferrante, MD
In patients undergoing emergency percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), several thrombectomy and distal protection devices have been evaluated in order to either remove thrombus and plaque...
In patients undergoing emergency percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), several thrombectomy and distal protection devices have been evaluated in order to either remove thrombus and plaque...
In patients undergoing emergency...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Liang Cui, MD; Tie Wang, MD; Yong-Gui Ge, MD; Hong-Shi Wang, MD; Wei-Ming Li, MD; Li Xu, MD; Zhu-Hua Ni, MD; Sheng-Hui Liu, MD; Lin Zhang, MD; Hui-Min Jia, MD; Jakob Vinten-Johansen, PhD; Zhi-Qing Zhao, MD, PhD; Yu Liu, PhD, MD; Xin-Chun Yang, MD; Le-Feng Wang, MD
Timely reperfusion is the most effective intervention to protect the heart from myocardial infarction resulting from coronary occlusion. However, experimental studies and clinical observations have provided strong evidence in support of the...
Timely reperfusion is the most effective intervention to protect the heart from myocardial infarction resulting from coronary occlusion. However, experimental studies and clinical observations have provided strong evidence in support of the...
Timely reperfusion is the most...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Cheng Wang, MD, PhD; Dean J. Kereiakes, MD, FACC, MSCAI; Jay P. Bae, PhD; Patrick McCollam, PharmD; Jianming He, MS; Brian Griffin, MBA
Current American College of Cardiology/American Heart Association guidelines for the treatment of unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) recommend initiation of clopidogrel treatment in patients for...
Current American College of Cardiology/American Heart Association guidelines for the treatment of unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) recommend initiation of clopidogrel treatment in patients for...
Current American College of...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Cindy W. Tom, MD; James J. Ferguson, III, MD
“Alle Ding’ sind Gift und nichts ohn’ Gift; allein die Dosis macht, dass ein Ding kein Gift ist” [ All things are poison and nothing is without poison; only the dose permits something not to be poison ] – ParacelsusAlthough he was born...
“Alle Ding’ sind Gift und nichts ohn’ Gift; allein die Dosis macht, dass ein Ding kein Gift ist” [ All things are poison and nothing is without poison; only the dose permits something not to be poison ] – ParacelsusAlthough he was born...
“Alle Ding’ sind Gift und nichts...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Prithwish Banerjee, MD, MRCP
Perhaps we interventionists should be more aware than we currently are of our patients’ left ventricular (LV) function or what angioplasty might do to that LV function. I am not suggesting that we don’t attach importance to this vital detail....
Perhaps we interventionists should be more aware than we currently are of our patients’ left ventricular (LV) function or what angioplasty might do to that LV function. I am not suggesting that we don’t attach importance to this vital detail....
Perhaps we interventionists...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Safi Shahda, MD; Michael Zahra, MD; Andrew Fiore, MD; Saadeh Jureidini, MD
Protein-losing enteropathy (PLE) is a serious, and if not treated, fatal complication of the Fontan-cavopulmonary anastomosis procedure.1 It has been suggested that creation of a fenestration may prevent2 and treat3,4 PLE in this setup. Other...
Protein-losing enteropathy (PLE) is a serious, and if not treated, fatal complication of the Fontan-cavopulmonary anastomosis procedure.1 It has been suggested that creation of a fenestration may prevent2 and treat3,4 PLE in this setup. Other...
Protein-losing enteropathy (PLE)...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
P. Syamasundar Rao, MD, FACC
Protein-losing enteropathy (PLE) may be defined as excessive loss of proteins across the intestinal mucosa and is due to either a primary gastrointestinal abnormality or secondary to cardiac disease. Initial reports of PLE secondary to...
Protein-losing enteropathy (PLE) may be defined as excessive loss of proteins across the intestinal mucosa and is due to either a primary gastrointestinal abnormality or secondary to cardiac disease. Initial reports of PLE secondary to...
Protein-losing enteropathy (PLE)...
08/01/2008
Journal of Invasive Cardiology